Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
451.63
-0.66 (-0.15%)
At close: Oct 26, 2026, 4:00 PM EDT
451.00
-0.63 (-0.14%)
After-hours: Oct 26, 2026, 5:11 PM EDT
Intuitive Surgical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,578 | 10,065 | 8,352 | 7,124 | 6,222 | 5,710 | |
Revenue Growth | 20.45% | 20.51% | 17.24% | 14.49% | 8.97% | 31.01% |
Cost of Revenue | 3,862 | 3,422 | 2,718 | 2,395 | 2,026 | 1,752 |
Gross Profit | 7,716 | 6,642 | 5,634 | 4,730 | 4,196 | 3,959 |
Selling, General & Admin | 2,552 | 2,385 | 2,140 | 1,964 | 1,712 | 1,467 |
Research & Development | 1,494 | 1,312 | 1,145 | 998.8 | 879 | 671 |
Operating Expenses | 4,045 | 3,697 | 3,285 | 2,963 | 2,591 | 2,138 |
Operating Income | 3,670 | 2,946 | 2,349 | 1,767 | 1,605 | 1,821 |
Interest & Investment Income | 322.8 | 380.9 | 327.6 | 195.8 | 78 | 80.8 |
Currency Exchange Gain (Loss) | 12.4 | -13 | -2.7 | -3.7 | -27.3 | -0.9 |
EBT Excluding Unusual Items | 4,006 | 3,313 | 2,674 | 1,959 | 1,656 | 1,901 |
Gain (Loss) on Sale of Investments | -0.3 | -2 | - | - | -21 | -10.6 |
Legal Settlements | -450 | - | - | - | -28.1 | - |
Pretax Income | 3,619 | 3,311 | 2,674 | 1,959 | 1,607 | 1,890 |
Income Tax Expense | 645.9 | 434.8 | 336.3 | 141.6 | 262.4 | 162.2 |
Earnings From Continuing Operations | 2,973 | 2,877 | 2,338 | 1,817 | 1,344 | 1,728 |
Minority Interest in Earnings | -15.9 | -20.6 | -14.9 | -19.3 | -22.1 | -23.5 |
Net Income | 2,957 | 2,856 | 2,323 | 1,798 | 1,322 | 1,705 |
Net Income to Common | 2,957 | 2,856 | 2,323 | 1,798 | 1,322 | 1,705 |
Net Income Growth | 7.66% | 22.97% | 29.18% | 35.98% | -22.43% | 60.72% |
Shares Outstanding (Basic) | 353 | 357 | 355 | 351 | 356 | 356 |
Shares Outstanding (Diluted) | 357 | 363 | 362 | 357 | 362 | 366 |
Shares Change | -1.75% | 0.19% | 1.29% | -1.27% | -1.04% | 1.33% |
EPS (Basic) | 8.37 | 8.00 | 6.54 | 5.12 | 3.72 | 4.79 |
EPS (Diluted) | 8.27 | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 |
EPS Growth | 9.47% | 22.59% | 27.63% | 37.81% | -21.67% | 58.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3,598 | 2,491 | 1,304 | 749.6 | 958.4 | 1,750 |
Free Cash Flow Per Share | 10.07 | 6.87 | 3.60 | 2.10 | 2.65 | 4.78 |
Gross Margin | 66.64% | 66.00% | 67.46% | 66.39% | 67.44% | 69.33% |
Operating Margin | 31.70% | 29.27% | 28.12% | 24.80% | 25.80% | 31.89% |
Profit Margin | 25.54% | 28.38% | 27.81% | 25.24% | 21.25% | 29.85% |
Free Cash Flow Margin | 31.08% | 24.75% | 15.61% | 10.52% | 15.40% | 30.65% |
EBITDA | 4,471 | 3,558 | 2,805 | 2,169 | 1,959 | 2,128 |
EBITDA Margin | 38.61% | 35.35% | 33.58% | 30.45% | 31.48% | 37.27% |
D&A For EBITDA | 800.3 | 612.5 | 455.7 | 402.2 | 353.8 | 307.4 |
EBIT | 3,670 | 2,946 | 2,349 | 1,767 | 1,605 | 1,821 |
EBIT Margin | 31.70% | 29.27% | 28.12% | 24.80% | 25.80% | 31.89% |
Effective Tax Rate | 17.85% | 13.13% | 12.58% | 7.23% | 16.33% | 8.58% |
Revenue as Reported | 11,578 | 10,065 | 8,352 | 7,124 | 6,222 | 5,710 |